Does a Transabdominal Plane Block Decrease Patient Pain After Ventral Hernia Repair?
| Status: | Completed |
|---|---|
| Conditions: | Post-Surgical Pain, Hospital, Gastrointestinal, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology, Musculoskeletal, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/21/2018 |
| Start Date: | August 2012 |
| End Date: | October 2014 |
Transabdominal Plane (TAP) Blocks in Ventral Hernia Repair
The purpose of this study is to determine if a Transabdominal Plane Block will decrease
patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical,
incisional) hernia repair with mesh.
patient pain and pain medication use after a laparoscopic ventral (ventral, umbilical,
incisional) hernia repair with mesh.
Patients coming in for a laparoscopic ventral (ventral, umbilical, incisional) hernia repair
with mesh are randomized to either receive a Transabdominal Plane Block injection or a
placebo saline injection. The injection will be performed by surgeons under direct
visualization during laparoscopic surgery prior to mesh placement. Patients will be followed
up post-operatively and after hospital discharge to assess for opioid usage and pain score.
Patients in both arms are medically cleared by the surgeon. Currently there are no studies
that look at the use of Transabdominal Plane Block in ventral hernia repairs.
with mesh are randomized to either receive a Transabdominal Plane Block injection or a
placebo saline injection. The injection will be performed by surgeons under direct
visualization during laparoscopic surgery prior to mesh placement. Patients will be followed
up post-operatively and after hospital discharge to assess for opioid usage and pain score.
Patients in both arms are medically cleared by the surgeon. Currently there are no studies
that look at the use of Transabdominal Plane Block in ventral hernia repairs.
Inclusion Criteria:
- age 18 and older
- elective laparoscopic ventral (ventral, umbilical, incisional) hernia repair at Mount
Sinai Hospital
Exclusion Criteria:
- age younger than 18
- allergic reaction to bupivacaine
- allergic reaction to opioids
- opioid substance abuse
We found this trial at
1
site
1428 Madison Ave
New York, New York 10029
New York, New York 10029
(212) 241-6500
Principal Investigator: Celia M Divino, MD, FACS
Phone: 212-241-4921
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
Click here to add this to my saved trials
